HEADER ANTIBIOTIC 05-FEB-10 2KTN TITLE SPATIAL STRUCTURE OF LCH-ALPHA PEPTIDE FROM TWO-COMPONENT LANTIBIOTIC TITLE 2 SYSTEM LICHENICIDIN VK21 COMPND MOL_ID: 1; COMPND 2 MOLECULE: LICHENICIDIN VK21 A1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 44-74 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS LICHENIFORMIS; SOURCE 3 ORGANISM_TAXID: 279010; SOURCE 4 STRAIN: VK21 KEYWDS LICHENICIDIN VK21, LANTIBIOTICS, LCHA, ANTIBIOTIC, LANTHIONINE, KEYWDS 2 THIOESTER, TWO-COMPONENT LANTIBIOTIC SYSTEM EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.S.MINEEV,Z.O.SHENKAREV,T.V.OVCHINNIKOVA,A.S.ARSENIEV REVDAT 6 10-AUG-11 2KTN 1 MODRES REVDAT 5 27-JUL-11 2KTN 1 REMARK REVDAT 4 13-JUL-11 2KTN 1 VERSN REVDAT 3 18-AUG-10 2KTN 1 SEQADV REVDAT 2 11-AUG-10 2KTN 1 KEYWDS MODRES REVDAT 1 21-JUL-10 2KTN 0 JRNL AUTH Z.O.SHENKAREV,E.I.FINKINA,E.K.NURMUKHAMEDOVA,S.V.BALANDIN, JRNL AUTH 2 K.S.MINEEV,K.D.NADEZHDIN,Z.A.YAKIMENKO,A.A.TAGAEV, JRNL AUTH 3 Y.V.TEMIROV,A.S.ARSENIEV,T.V.OVCHINNIKOVA JRNL TITL ISOLATION, STRUCTURE ELUCIDATION, AND SYNERGISTIC JRNL TITL 2 ANTIBACTERIAL ACTIVITY OF A NOVEL TWO-COMPONENT LANTIBIOTIC JRNL TITL 3 LICHENICIDIN FROM BACILLUS LICHENIFORMIS VK21. JRNL REF BIOCHEMISTRY V. 49 6462 2010 JRNL REFN ISSN 0006-2960 JRNL PMID 20578714 JRNL DOI 10.1021/BI100871B REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KTN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAR-10. REMARK 100 THE RCSB ID CODE IS RCSB101559. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : 3.5 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM LCHA-1, 500 MG [U-100% REMARK 210 2H] METHANOL-2, METHANOL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H COSY; 2D 1H-1H NOESY; REMARK 210 2D 1H-1H TOCSY; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.5.3, TOPSPIN 2.1, CYANA REMARK 210 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 LICHENICIDIN VK21 A1 IS A LINEAR LANTIBIOTIC. THE LANTIBIOTICS REMARK 400 ARE CHARACTERIZED BY LANTHIONINE AND/OR METHYLLANTHIONINE REMARK 400 NONPROTEINOGENIC AMINO ACIDS. REMARK 400 HERE, LICHENICIDIN VK21 A1 IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: LICHENICIDIN VK21 REMARK 400 CHAIN: A REMARK 400 COMPONENT_1: PEPTIDE LIKE SEQUENCE RESIDUES 1 TO 32 REMARK 400 DESCRIPTION: LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. THIOETHER REMARK 400 BONDS WITH CYSTEINE RESULT IN FOUR RINGS REMARK 400 CROSSLINK 3-7 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 11-21 LANTHIONINE (DAL-CYS) REMARK 400 CROSSLINK 22-27 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 400 CROSSLINK 24-31 BETA-METHYLLANTHIONINE (DBB-CYS) REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 MODELS 1-20 REMARK 470 RES CSSEQI ATOMS REMARK 470 2KT A 1 O2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O DBB A 24 N GLU A 26 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 4 129.07 -30.82 REMARK 500 1 LEU A 10 34.48 -83.83 REMARK 500 1 DAL A 11 170.39 -44.56 REMARK 500 1 LYS A 12 130.19 173.93 REMARK 500 1 LEU A 14 -164.85 44.63 REMARK 500 1 ASN A 17 -80.84 -179.50 REMARK 500 1 TYR A 19 -175.30 -54.96 REMARK 500 1 LEU A 20 47.73 -75.67 REMARK 500 1 LYS A 25 -35.51 -23.81 REMARK 500 2 LEU A 4 129.63 -30.61 REMARK 500 2 LYS A 12 80.99 -150.09 REMARK 500 2 ASN A 17 178.01 -54.43 REMARK 500 2 TYR A 19 -166.56 -76.98 REMARK 500 2 LEU A 20 157.62 -44.97 REMARK 500 2 LYS A 25 -35.42 -23.70 REMARK 500 2 SER A 30 26.99 -78.63 REMARK 500 3 LEU A 4 130.07 -30.70 REMARK 500 3 DAL A 11 177.95 -65.66 REMARK 500 3 PRO A 13 -163.70 -69.73 REMARK 500 3 LEU A 14 -163.58 -57.22 REMARK 500 3 ASN A 16 -164.98 46.27 REMARK 500 3 ASN A 17 -70.15 -44.95 REMARK 500 3 LYS A 25 -35.50 -23.58 REMARK 500 3 SER A 30 27.87 -78.68 REMARK 500 4 LEU A 4 129.23 -30.69 REMARK 500 4 CYS A 7 -82.77 -56.98 REMARK 500 4 LEU A 10 40.02 -90.22 REMARK 500 4 PRO A 13 -163.83 -69.71 REMARK 500 4 ASN A 16 -172.50 -54.07 REMARK 500 4 TYR A 19 -162.72 -56.75 REMARK 500 4 LYS A 25 -36.09 -22.99 REMARK 500 4 SER A 30 26.98 -79.25 REMARK 500 4 CYS A 31 40.46 -91.00 REMARK 500 5 LEU A 4 129.50 -30.70 REMARK 500 5 DAL A 11 -140.56 -65.56 REMARK 500 5 PRO A 13 -175.31 -69.81 REMARK 500 5 LEU A 14 -163.75 -79.51 REMARK 500 5 ASN A 16 95.58 44.45 REMARK 500 5 ASN A 17 -177.85 53.42 REMARK 500 5 TYR A 19 -169.75 -106.04 REMARK 500 5 LYS A 25 -35.54 -23.51 REMARK 500 5 SER A 30 27.58 -78.60 REMARK 500 6 LEU A 4 132.19 -30.70 REMARK 500 6 LYS A 12 80.96 34.34 REMARK 500 6 ASN A 16 -166.64 -54.76 REMARK 500 6 ASN A 17 -85.37 49.89 REMARK 500 6 TYR A 19 -175.05 -58.26 REMARK 500 6 LYS A 25 -35.38 -23.83 REMARK 500 6 SER A 30 28.04 -78.73 REMARK 500 7 LEU A 4 129.61 -30.72 REMARK 500 REMARK 500 THIS ENTRY HAS 157 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AJ1 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC ACTAGARDINE REMARK 900 RELATED ID: 1MQX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN REMARK 900 MEOH/H2O MIXTURE REMARK 900 RELATED ID: 1MQY RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN IN DPC REMARK 900 MICELLES REMARK 900 RELATED ID: 1MQZ RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF TYPE B LANTIBIOTICS MERSACIDIN BOUND REMARK 900 TO LIPID II IN DPC MICELLES REMARK 900 RELATED ID: 1QOW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TUPE B LANTIBIOTIC MERSACIDIN REMARK 900 RELATED ID: 1W9N RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC EPILANCIN 15X REMARK 900 RELATED ID: 1WCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF NISIN AND LIPID II COMPLEX REMARK 900 RELATED ID: 2DDE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LANTIBIOTIC CINNAMYCIN COMPLEXED REMARK 900 WITH LYSOPHOSPHATIDYLETHANOLAMINE REMARK 900 RELATED ID: 2KTO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF LCH-BETA PEPTIDE FROM TWO-COMPONENT REMARK 900 LANTIBIOTIC LICHENICIDIN VK21 A2 DBREF 2KTN A 1 32 UNP P86475 LANLA_BACLI 43 74 SEQRES 1 A 32 2KT ILE DBB LEU DHA DBU CYS ALA ILE LEU DAL LYS PRO SEQRES 2 A 32 LEU GLY ASN ASN GLY TYR LEU CYS DBB VAL DBB LYS GLU SEQRES 3 A 32 CYS MET PRO SER CYS ASN MODRES 2KTN DBB A 3 THR POST-TRANSLATIONAL MODIFICATION MODRES 2KTN DHA A 5 ALA POST-TRANSLATIONAL MODIFICATION MODRES 2KTN DBU A 6 THR POST-TRANSLATIONAL MODIFICATION MODRES 2KTN DAL A 11 SER POST-TRANSLATIONAL MODIFICATION MODRES 2KTN DBB A 22 THR POST-TRANSLATIONAL MODIFICATION MODRES 2KTN DBB A 24 THR POST-TRANSLATIONAL MODIFICATION HET 2KT A 1 11 HET DBB A 3 12 HET DHA A 5 8 HET DBU A 6 11 HET DAL A 11 9 HET DBB A 22 12 HET DBB A 24 12 HETNAM 2KT 2-KETOBUTYRIC ACID HETNAM DBB D-ALPHA-AMINOBUTYRIC ACID HETNAM DHA 2-AMINO-ACRYLIC ACID HETNAM DBU (2Z)-2-AMINOBUT-2-ENOIC ACID HETNAM DAL D-ALANINE HETSYN 2KT 2-OXOBUTANOIC ACID HETSYN DHA 2,3-DIDEHYDROALANINE HETSYN DBU Z-DEHYDROBUTYRINE FORMUL 1 2KT C4 H6 O3 FORMUL 1 DBB 3(C4 H9 N O2) FORMUL 1 DHA C3 H5 N O2 FORMUL 1 DBU C4 H7 N O2 FORMUL 1 DAL C3 H7 N O2 HELIX 1 1 VAL A 23 CYS A 27 5 5 LINK C1 2KT A 1 N ILE A 2 1555 1555 1.33 LINK C ILE A 2 N DBB A 3 1555 1555 1.32 LINK C DBB A 3 N LEU A 4 1555 1555 1.33 LINK CB DBB A 3 SG CYS A 7 1555 1555 1.82 LINK C LEU A 4 N DHA A 5 1555 1555 1.33 LINK C DHA A 5 N DBU A 6 1555 1555 1.33 LINK C DBU A 6 N CYS A 7 1555 1555 1.33 LINK C LEU A 10 N DAL A 11 1555 1555 1.32 LINK C DAL A 11 N LYS A 12 1555 1555 1.33 LINK CB DAL A 11 SG CYS A 21 1555 1555 1.81 LINK C CYS A 21 N DBB A 22 1555 1555 1.32 LINK CB DBB A 22 SG CYS A 27 1555 1555 1.82 LINK C DBB A 22 N VAL A 23 1555 1555 1.33 LINK C VAL A 23 N DBB A 24 1555 1555 1.32 LINK CB DBB A 24 SG CYS A 31 1555 1555 1.87 LINK C DBB A 24 N LYS A 25 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 194 0 7 1 0 0 0 6 0 0 0 3 END